Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status
Martina Broecker‐Preuss(Essen University Hospital), Dagmar Führer(University of Duisburg-Essen)
Cited by 53
Related Papers
Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability
|Journal of Translational Medicine|2017|55
Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cells
|Journal of Experimental & Clinical Cancer Research|2015|18
Dissecting Molecular Events in Thyroid Neoplasia Provides Evidence for Distinct Evolution of Follicular Thyroid Adenoma and Carcinoma
|American Journal Of Pathology|2011|15